Open access · OA
via Europe PMC
Mesenchymal Stem Cells and Extracellular Vesicles for Neurodegenerative Diseases: Therapeutic Advances and Challenges.
Pan L, Liu B, Xu J, Mu X, Fan L.
International journal of nanomedicine · 2026
Stem-cell exhaustion
Stem-cell therapy
Human
Systematic review
Preclinical / animal
Meta-analysis
Review
Abstract
Mesenchymal stem cells (MSCs), as a type of adult stem cells, exhibit robust self-renewal, multi-lineage differentiation, paracrine and immunomodulatory capacities, demonstrating broad application prospects in the treatment of neurodegenerative diseases. This review systematically summarizes the mechanisms of action, therapeutic advances and comparative analyses of various MSCs and their derived extracellular vesicles (EVs) in Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), and discusses the optimization effects of gene modification and pretreatment on therapeutic efficacy. This article not only highlights the advantages of various MSCs and their corresponding EVs, but also provides unique insights into their differentiated therapeutic potential and mechanism of action, which have not been fully elucidated in previous studies. Meanwhile, although current research results are encouraging, this paper also critically points out that existing studies suffer from insufficient elucidation of mechanisms and lack of large-scale clinical trials. Finally, the article prospects future directions of MSC-based therapeutic strategies, including mechanism deepening, treatment optimization and standardization system construction, to promote their translation into clinical application. However, most of the current evidence is still preclinical, and the recognized clinical efficacy in humans is still limited. This is a narrative review. Literature was screened from Web of Science and PubMed by thematic relevance and research quality, without systematic review protocol or meta-analysis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.2147/ijn.s628071
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
L, P., B, L., J, X., X, M., & L., F. (2026). Mesenchymal Stem Cells and Extracellular Vesicles for Neurodegenerative Diseases: Therapeutic Advances and Challenges. <em>International journal of nanomedicine</em>. https://doi.org/10.2147/ijn.s628071
Vancouver
L P, B L, J X, X M, L. F. Mesenchymal Stem Cells and Extracellular Vesicles for Neurodegenerative Diseases: Therapeutic Advances and Challenges. International journal of nanomedicine. 2026. doi:10.2147/ijn.s628071.
BibTeX
@article{pan2026Mesenc,
title = {Mesenchymal Stem Cells and Extracellular Vesicles for Neurodegenerative Diseases: Therapeutic Advances and Challenges.},
author = {Pan L and Liu B and Xu J and Mu X and Fan L.},
journal = {International journal of nanomedicine},
year = {2026},
doi = {10.2147/ijn.s628071},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cell Research & Therapy 2025
Open access · CC-BY
Advances in mesenchymal stem cell and exosome-based therapies for aging and age-related diseases
Signal Transduction and Targeted Therapy 2025
Open access · CC-BY
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
Biomaterials Research 2016
Open access · CC-BY
Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases
Frontiers in Immunology 2023
Open access · CC-BY
Mechanism of mesenchymal stem cells and exosomes in the treatment of age-related diseases
World Journal of Gastroenterology 2015
Open access · CC-BY
Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives
Advances in Wound Care 2012
Open access · OA